Biography
I am a clinician and researcher specializing in the care of patients with both Non Hodgkin and Hodgkin lymphomas. Areas of particular interest include aggressive B-cell lymphomas such as diffuse large B-cell lymphoma and "double hit" lymphoma, autologous stem cell transplantation and cellular therapy including chimeric antigen receptor (CAR) T-cells.
Lymphomas are a complex group of diseases and require a multidisciplinary team to manage. We are fortunate to have an excellent team at the Wilmot Cancer Institute including hematology and oncology, radiation oncology, hematopathology, dermatology, neurology, nursing, advanced practice providers, social work and members of the clinical trials office.
I am actively engaged in clinical trials research and feel that this is an important component of care for lymphoma patients.
My lymphoma practice team includes Taylor Fox, NP and Abir Hines, RN. My team for autologous stem cell transplantation and CAR T-cells includes Anna Morrison, RN.
Professional Background
Dr. Reagan is an Assistant Professor of Medicine at the Wilmot Cancer Institute.
Dr. Reagan received his medical degree from Upstate Medical University in Syracuse, NY. He completed his internship and residency at the University of Virginia. He then served as a chief resident at the University of Virginia. He completed his fellowship in hematology at the Wilmot Cancer Institute at the University of Rochester Medical Center.
He started his faculty appointment at the Wilmot Cancer Institute in July 2015.
Credentials
Specialties
- Hematology - American Board of Internal Medicine
- Internal Medicine - American Board of Internal Medicine
Education
2005
BS | St. Lawrence University
Neuroscience
2009
MD | SUNY Upstate Medical University
Medicine
2009-2012
| University of Virginia
Resident
2012-2013
| University of Virginia
Chief Resident
2013-2015
| University of Rochester, Rochester, NY
Fellow in Hematology
Post-doctoral Training & Residency
07/01/2013 - 06/30/2015
Fellowship in Hematology/Oncology at University of Rochester Medical Center - GME Office
07/01/2012 - 07/01/2013
Residency in Internal Medicine at University of Virginia Children's Hospital
07/01/2010 - 07/01/2012
Residency in Internal Medicine at University of Virginia Children's Hospital
07/01/2009 - 7/1/2010
Internship in Internal Medicine at University of Virginia Children's Hospital
VIEW ALL expand_more
Awards
2018
Lymphoma Research Foundation Clinical Research Mentoring Program
2015
American Society of Hematology Clinical Research Training Institute
2014
John and Carol Bennett Travel Fellowship Award
Sponsor: John and Carol Bennett
Location: Wilmot Cancer Institute
2009
Alpha Omega Alpha, Upstate Medical University
Sponsor: Upstate Medical University
2005
Phi Beta Kappa, St. Lawrence University
Sponsor: St. Lawrence University
2004
Academic All American, Football, St. Lawrence University
Sponsor: St. Lawrence University
Beta Beta Beta, Biological Honor Society, St. Lawrence University
Sponsor: St. Lawrence University
VIEW ALL expand_more
Publications
Journal Articles
7/8/2019
Loh KP, Baran A, Lee CY, Alshaibani A, Rutherford SC, Hu J, Casulo C, Barr PM, Friedberg JW, Reagan PM. "Patients with diffuse large B-cell lymphoma requiring urgent treatment: its implication on trial design and interpretation." Leukemia & lymphoma.. 2019 Jul 8; :1-4. Epub 2019 Jul 08.
5/28/2019
Tomlinson SB, Sandwell S, Chuang ST, Johnson MD, Vates GE, Reagan PM. "Central nervous system relapse of systemic ALK-rearranged anaplastic large cell lymphoma treated with alectinib." Leukemia research.. 2019 May 28; 83:106164. Epub 2019 May 28.
11/30/2018
"Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1-2 trial." The Lancet. Oncology.. 2018 Nov 30; Epub 2018 Nov 30.
Books & Chapters
2018
Chapter Title: Targeting the B-cell receptor pathway: a review of current and future therapies for non-Hodgkin's lymphoma. Expert Opinion on Emerging Drugs. 2018 2018/04/03;23(2):111-22.
Book Title: Targeting the B-cell receptor pathway
Author List: Rodgers TD, Reagan PM
Published By: Emerging Drugs 2018
2017
Chapter Title: Current treatment of double hit and double expressor lymphoma. Hematology American Society of Hematology Education Program, 2017. 2017(1): p 295-297.
Book Title: Hematology American Society of Hematology Education Program
Author List: Reagan, P.M. and A. Davies
Published By: Hematology American Society of Hematology Education Program 2017
2017
Chapter Title: Reassessment of Anti-CD20 Therapy in Lymphoid Malignancies: Impact, (Williston Park), 2017. 31(5): p. 402-11.
Book Title: Reassessment of Anti-CD20 Therapy in Lymphoid Malignancies: Impact,
Author List: Reagan, P.M. and J.W. Friedberg
Published By: Limitations, and New Directions. Oncology 2017
VIEW ALL PUBLICATIONS